Nalgene bottles and carboys meet lab standards

Published: 31-Aug-2011
Manufacturing Packaging Analysis

Thermo Fisher provides high-quality leakproof containers

Thermo Fisher Scientific is offering Nalgene bottles, carboys and containers for a range of applications, in sizes ranging from 4ml to 50L.

In addition, each bottle comes with a leakproof guarantee and is available in a range of certified resins for laboratory, food and pharmaceutical use.

The complete portfolio of Nalgene bottles and containers come in a variety of sizes and shapes, with both narrow and wide mouths.

Classic standard Nalgene lab quality bottles provide performance and protection, while Nalgene economy bottles are lighter-weight versions of the original, designed for light-duty, general-purpose laboratory applications.

Thermo Fisher says both ranges are produced in an ISO-certified facility with high lot-to-lot consistency, assuring consistent quality, uniform wall thickness and reliability.

Nalgene bottles and containers are also available in a variety of materials, each with specific properties for chemical resistance, autoclavability, inertness and temperature tolerance.

Thermo Fisher offers an online bottle and selection guide, at www.thermoscientific.com/safecontainer, to assist users in choosing the optimal container for each application.

  • Companies:
  • Thermo Fisher Scientific
See more

You may also like

Manufacturing

Thermo Fisher teams up with Xcellbio to further cell and gene therapy research

Read more
The pair will focus on Treg and TIL research, with the intention of developing therapeutics for autoimmune and solid tumour diseases

Trending Articles

  1. RCPE and InSilicoTrials to digitalise and accelerate the development of pharmaceutical manufacturing processes RCPE and InSilicoTrials have agreed to an exclusive partnership to commercialise the XPS simulation software. Specifically developed for pharmaceutical applications, XPS allows companies to assess their process configurations in unprecedented detail and explore the decision space without time- and labour-intensive experiments
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    How onco-HPAPI manufacturing is adapting to a new era The oncology landscape is undergoing a quiet but powerful shift. Pharmaceutical companies, once focused primarily on novel compounds, are now increasingly exploring repurposing opportunities with existing high-potency oncology APIs (onco-HPAPIs)
  3. Merck launches AAW Workstation to advance lab automation New platform powered by Opentrons expands lab automation to accelerate scientific discovery
  4. Molecular Devices unveils next-generation SpectraMax Multi-Mode Microplate Readers Honouring a legacy of product line reliability and strength, the SpectraMax Multi-Mode Microplate Readers have been transformed with next-generation innovation to improve research capabilities and provide unparalleled flexibility for a wide range of assays and applications
  5. A forward-thinking approach to reducing downtime and costs in the pharmaceutical industry Implementing predictive maintenance and a lifecycle package can significantly reduce both downtime and costs in the pharmaceutical industry, emphasises Benoit Dehaene from GEA Pharma & Healthcare

Upcoming event

POWTECH

23-25 September 2025 | Exhibition | Nuremberg, Germany See all

You may also like

Manufacturing

Thermo Fisher teams up with Xcellbio to further cell and gene therapy research

The pair will focus on Treg and TIL research, with the intention of developing therapeutics for autoimmune and solid tumour diseases
Manufacturing

Thermo Fisher's Accelerator CDMO and CRO solutions can slash drug development times by 3 years, study finds

The centralised solution can streamline the drug development process, facilitating the rapid commercialisation of new therapeutics
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Accelerating therapeutic manufacturing with smart and sustainable technologies

In this article, John Puglia, Senior Director of Research and Development, Single-Use Technologies, at Thermo Fisher Scientific, explores how innovative technologies are revolutionising biomanufacturing for a smarter, more sustainable future
Manufacturing

Ethris and Thermo Fisher Scientific to provide mRNA technology to biopharma market

Ethris will combine its mRNA technology platforms with Thermo Fisher's GMP manufacturing capacity to serve the biopharmaceutical market
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

Unlocking the secrets of cells: the revolutionary power of spatial biology

Spatial biology is the study of biomolecules and cells within their native tissue microenvironment. This approach has enabled scientists to develop a better understanding of cell interactions in their natural locations
Manufacturing

Thermo Fisher Scientific to invest $2bn into US manufacturing capabilities

The life science service provider will put 75% of the $2bn into its US pharmaceutical manufacturing capacities, helping to produce key medicines for the market
Manufacturing

Thermo Fisher Scientific introduces the 5L DynaDrive Single-Use Bioreactor

First-of-its-kind bench scale bioreactor enabling productivity, scalability and efficiency supporting reduced environmental impact; to simplify and accelerate process development and help bring therapies to market faster
Subscribe now